文献速递肝病

美国全国队列研究:慢加急性肝衰竭的患病率与短期死亡率

Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.
PubMed 文献 · J Hepatol · 2018-12-25

基于美国退伍军人事务部127家医院2004至2014年数据,72,316例失代偿期肝硬化住院患者中19,082例(26.4%)入院时符合慢加急性肝衰竭(ACLF)标准。ACLF患者28天和90天死亡率分别为25.5%和40.0%。研究期间ACLF患病率下降,除ACLF-3外各分级生存率改善。

要点

  • 失代偿期肝硬化住院患者中约四分之一(26.4%)符合ACLF标准。
  • ACLF患者28天死亡率为25.5%,90天死亡率为40.0%。
  • 研究期间ACLF患病率下降,但ACLF-3生存率未见改善。

核心结论

  • 在美国失代偿期肝硬化住院患者队列中,ACLF常见且与高短期死亡率相关。
  • 研究期间ACLF患病率下降,但未观察到ACLF-3的生存率改善。
  • 作者认为早期识别和积极管理包括及时转诊至移植中心可能改善ACLF结局。

研究设计与样本

  • 利用美国退伍军人事务部企业数据仓库,识别2004年1月1日至2014年12月31日期间在127家退伍军人事务部医院因失代偿期肝硬化住院并符合ACLF标准的患者。
  • 共纳入72,316例因失代偿期肝硬化住院的患者,其中19,082例(26.4%)入院时符合ACLF标准。
  • 分析ACLF患病率、与28天和90天死亡率相关的变量,以及患病率和生存率随时间的变化趋势。

主要发现

  • 19,082例ACLF患者中,12.8%有1个器官衰竭,10.1%有2个器官衰竭,3.5%有3个或以上器官衰竭。
  • ACLF患者28天死亡率为25.5%,90天死亡率为40.0%。
  • 年龄较大、白人种族、肝癌、较高的终末期肝病模型钠校正评分以及非肝移植中心与ACLF死亡风险增加相关。
  • 研究期间ACLF患病率下降,除ACLF-3外各分级生存率均有改善。

关键数值与推荐

  • ACLF定义为失代偿期肝硬化患者出现器官衰竭。
  • 器官衰竭数量分布:1个器官衰竭12.8%,2个器官衰竭10.1%,3个或以上器官衰竭3.5%。
  • 28天死亡率25.5%,90天死亡率40.0%。

临床怎么用

  • 作者认为早期识别ACLF对于启动积极管理很重要,积极管理是挽救这些患者生命所必需的。
  • 作者认为包括及时转诊至移植中心在内的积极管理可能改善ACLF结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Acute-on-chronic liver failure (ACLF) is characterised by the presence of organ failure in patients with decompensated cirrhosis and is associated with high short-term mortality. However, there are limited data on the prevalence and short-term outcomes of ACLF in patients with cirrhosis seen in the US. We aimed to study the prevalence and risk factors associated with the development and short term mortality in a large cohort of patients in the US. METHODS: Using the US Department of Veterans Affairs (VA) Corporate Data Warehouse, we identified patients with ACLF during hospitalisation for decompensated cirrhosis at any of the 127 VA hospitals between January 1, 2004, and December 31, 2014. We examined the prevalence of ACLF and variables associated with 28- and 90-day mortality in ACLF, and trends in prevalence and survival over time. RESULTS: Of 72,316 patients hospitalised for decompensated cirrhosis, 19,082 (26.4%) patients met the criteria of ACLF on admission. Of these, 12.8% had 1, 10.1% had 2, and 3.5% had 3 or more organ failures. Overall, 25.5% and 40.0% of ACLF patients died within 28 days and 90 days of admission, respectively. Older age, White race, liver cancer, higher model for end-stage liver disease sodium corrected score, and non-liver transplant centre were associated with increased risk of death in ACLF. Over the study period, the prevalence of ACLF decreased, and all grades but ACLF-3 had improvement in survival. CONCLUSIONS: In a US cohort of hospitalised patients with decompensated cirrhosis, ACLF was common and associated with high short-term mortality. Over a decade, ACLF prevalence decreased but survival improvement of ACLF-3 was not seen. Early recognition and aggressive management including timely referral to transplant centres may lead to improved outcomes in ACLF. LAY SUMMARY: Acute-on-chronic liver failure (ACLF) is a condition marked by multiple organ failures in patients with cirrhosis and associated with a high risk of death. In this study of US patients hospitalised with cirrhosis, 1 in 4 patients developed ACLF. In total, 25% of patients with ACLF died within 1 month and 40% died within 3 months. Thus, early recognition of ACLF is important for the initiation of aggressive management, which is required to save these patients' lives.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Hernaez R, Kramer JR, Liu Y, et al. Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. J Hepatol. 2018. PMID: 30590100. doi:10.1016/j.jhep.2018.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。